Market Overview:
The global diabetes diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in diabetes diagnostics, and rising demand for point-of-care testing. Based on type, the global diabetes diagnostics market is segmented into continuous glucose monitoring (CGM) systems, self-monitoring glucose meters (SGLMs), and others. The CGM systems segment is expected to grow at the highest CAGR during the forecast period owing to technological advancements in this segment that have made these systems more accurate and user-friendly. Based on application, the global diabetes diagnostics market is divided into hospitals and clinics, home healthcare, and others. The hospitals and clinics segment dominates this market due to increased awareness about early diagnosis of diabetes among patients visiting these healthcare facilities for other reasons such as treatment for other diseases or checkups. However, with increasing preference for home healthcare by patients owing to convenience factors such as lower costs and no need for appointments/waiting times; this segment is projected to grow at a higher rate than other segments during the forecast period.
Product Definition:
Diabetes Diagnostics is a branch of medicine that deals with the diagnosis and treatment of diabetes. It is important for diagnosing diabetes because it helps to determine the type and severity of the disease.
Continuous Glucose Monitoring (CGM) Systems:
Continuous glucose monitoring systems are medical devices used to monitor blood sugar levels. These devices are gaining popularity owing to the associated benefits such as early diagnosis and prevention of diabetes, which in turn is expected to drive the market growth over the forecast period. The introduction of technological advanced products with improved accuracy and portability is also anticipated to fuel product demand over the next few years.
Self-monitoring Glucose Meters:
Self-monitoring glucose meters (SMGMs) are devices used to measure blood sugar levels. They are small in size, easy to use and provide instant results. Self-monitoring of blood glucose (SMBG) is an effective way for diabetes patients to manage their disease as it provides them with the freedom to move around and perform their daily activities without depending on any third party for assistance.
Application Insights:
The others segment includes diabetes education and training, patient support and follow-up care, research studies, and commercial testing. The hospital & clinic segment dominated the market in terms of revenue in 2017. Continuous glucose monitoring is used extensively by patients with diabetes for pre-meal tests as well as overnight fasting blood sugar levels. These factors are responsible for driving the growth of this segment.
On the other hand, home healthcare is expected to be fastest growing application over forecast period owing to increasing awareness about CGM devices among individuals suffering from diabetes mellitus coupled with rising adoption of these devices at home by individuals who require continuous monitoring of their blood glucose levels without visiting a healthcare facility frequently or spending excessive amounts on medical consultations every year regarding management or treatment related issues associated with type 2 diabetes mellitus or its complications along with an increased number of clinical trials being conducted globally on a regular basis that focus on improving diagnosis methods for type 2 diabetic patients which eventually benefits overall demand over forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of diabetes and growing adoption of advanced technologies in this region. Asia Pacific is anticipated to grow at a lucrative rate over the forecast period owing to rising diabetic population, improving healthcare infrastructure, and increasing awareness about CGM systems among patients. Moreover, economic development coupled with improvement in healthcare facilities will boost growth further. In addition, government initiatives are also being undertaken in order for proper diagnosis and treatment of diabetes through continuous glucose monitoring system devices which will drive demand further over the next eight years (2018-2030).
The product launch by major players such as Abbott Diabetes Care Pvt Ltd., Medtronic Diabetes Inc.; Novo Nordisk A/S; Roche Diagnostics Corporation; DiaSorin Ltd.; FreeStyle Navigator; Dexcom GmbH & Co., Inc.
Growth Factors:
- Increasing incidence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for diagnostic tests for diabetes.
- Technological advancements: Diabetes diagnostics market is witnessing rapid technological advancements, which are helping in the development of novel and more accurate diagnostic tests. This is aiding in the growth of this market significantly.
- Growing awareness about diabetes: There has been a significant increase in awareness about diabetes among people across the world in recent years. This has led to an increase in demand for diagnostic tests for diabetes diagnosis and treatment options thereof..
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Diagnostics Market Research Report
By Type
Continuous Glucose Monitoring (CGM) Systems, Self-monitoring Glucose Meters, Others
By Application
Hospitals and Clinics, Home Healthcare, Others
By Companies
Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, GlySens Incorporated, Sinocare, San Meditech, Bayer, Nemaura Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Diagnostics Market Report Segments:
The global Diabetes Diagnostics market is segmented on the basis of:
Types
Continuous Glucose Monitoring (CGM) Systems, Self-monitoring Glucose Meters, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Home Healthcare, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dexcom
- Abbott Laboratories
- Medtronic
- Senseonics Holdings
- GlySens Incorporated
- Sinocare
- San Meditech
- Bayer
- Nemaura Medical
Highlights of The Diabetes Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Continuous Glucose Monitoring (CGM) Systems
- Self-monitoring Glucose Meters
- Others
- By Application:
- Hospitals and Clinics
- Home Healthcare
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes Diagnostics is a company that provides diabetes testing and management products. The company's products include blood glucose meters, insulin pumps, and other diabetes-related supplies.
Some of the major companies in the diabetes diagnostics market are Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, GlySens Incorporated, Sinocare, San Meditech, Bayer, Nemaura Medical.
The diabetes diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Diabetes Diagnostics Market Size and Y-o-Y Growth
4.5.2 Diabetes Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Diabetes Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diabetes Diagnostics Market Size Forecast by Type
5.2.1 Continuous Glucose Monitoring (CGM) Systems
5.2.2 Self-monitoring Glucose Meters
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diabetes Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diabetes Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Home Healthcare
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diabetes Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Diabetes Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diabetes Diagnostics Market Size Forecast by Type
9.6.1 Continuous Glucose Monitoring (CGM) Systems
9.6.2 Self-monitoring Glucose Meters
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diabetes Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Home Healthcare
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diabetes Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Diabetes Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diabetes Diagnostics Market Size Forecast by Type
10.6.1 Continuous Glucose Monitoring (CGM) Systems
10.6.2 Self-monitoring Glucose Meters
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diabetes Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Home Healthcare
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diabetes Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diabetes Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diabetes Diagnostics Market Size Forecast by Type
11.6.1 Continuous Glucose Monitoring (CGM) Systems
11.6.2 Self-monitoring Glucose Meters
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diabetes Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Home Healthcare
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diabetes Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Diabetes Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diabetes Diagnostics Market Size Forecast by Type
12.6.1 Continuous Glucose Monitoring (CGM) Systems
12.6.2 Self-monitoring Glucose Meters
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diabetes Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Home Healthcare
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diabetes Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diabetes Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diabetes Diagnostics Market Size Forecast by Type
13.6.1 Continuous Glucose Monitoring (CGM) Systems
13.6.2 Self-monitoring Glucose Meters
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diabetes Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Home Healthcare
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Diagnostics Market: Competitive Dashboard
14.2 Global Diabetes Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dexcom
14.3.2 Abbott Laboratories
14.3.3 Medtronic
14.3.4 Senseonics Holdings
14.3.5 GlySens Incorporated
14.3.6 Sinocare
14.3.7 San Meditech
14.3.8 Bayer
14.3.9 Nemaura Medical
